exendin-4 vs semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Semaglutide (Ozempic): From Lizard Spit
Description
van Andel, Beekman, F., & J
When patients discontinue Wegovy, research shows approximately 5070% of lost weight returns within one year because appetite hormones and metabolic rate revert to pre-treatment levels
Your lab work and comprehensive consultation ensure theyre appropriate for your specific health profile before any medication is initiated
Losing weight without the assistance of drugs or other medical interventions can look different to doing so using glucagon-like peptide-1 (GLP-1) receptor agonists
By understanding what is happening beneath the surface, treatment plans can be tailored to address each patients unique needs rather than relying on a one-size-fits-all approach
Monami et al evaluated changes in lipid levels with GLP-1RA versus placebo in a meta-analysis
